Long-term Combination Therapy with Anti-TNF plus Vedolizumab Induces and Maintains Remission in Therapy-refractory Ulcerative Colitis

Long-term Combination Therapy with Anti-TNF plus Vedolizumab Induces and Maintains Remission in Therapy-refractory Ulcerative Colitis American Journal of Gastroenterology 112, 1621 (October 2017). doi:10.1038/ajg.2017.242 Authors: Sarah Fischer, Timo Rath, Carol-Immanuel Geppert, Bernhard Manger, Georg Schett, Markus F Neurath & Raja Atreya
Source: The American Journal of Gastroenterology - Category: Gastroenterology Authors: Source Type: research